People taking GLP-1 medications like Ozempic face heightened health risks during hot weather, experts warn. These drugs, which slow stomach emptying and reduce appetite, compound the body's difficulty regulating temperature and staying hydrated in summer conditions.
The concern centers on two main mechanisms. GLP-1 agonists delay gastric emptying, meaning food and fluids move through the digestive system more slowly. This reduces the speed at which the body absorbs water and electrolytes, leaving patients more vulnerable to dehydration. Additionally, these medications suppress appetite signals, which can cause people to drink and eat less precisely when their bodies need more fluids and nutrients.
Heat intensifies these risks. Warm temperatures naturally increase fluid loss through perspiration. When combined with GLP-1 use, the body struggles to replenish what it loses. Dehydration then triggers a cascade of problems: reduced blood volume, electrolyte imbalances, dizziness, fainting, and in severe cases, heat exhaustion or heat stroke.
Healthcare providers recommend several protective steps for patients on these medications during summer. Drink water consistently throughout the day, even without feeling thirsty. GLP-1 users should monitor urine color as a hydration marker. Pale urine indicates adequate hydration; dark urine signals dehydration. Eat small, frequent meals rich in water-dense foods like fruits and vegetables. Avoid prolonged sun exposure, especially midday heat. Wear lightweight, light-colored clothing and use sunscreen.
People on GLP-1 medications should also watch for warning signs. Dizziness, excessive fatigue, rapid heartbeat, or confusion warrant immediate medical attention. Those planning vacations or activities in hot climates should discuss heat-specific precautions with their prescribing physician before traveling.
The message is clear. GLP